Results 231 to 240 of about 26,342,104 (415)

Characteristics of Secretory Immune System in Human Middle Ear: Implications in Otitis Media [PDF]

, 1974
Pearay L. Ogra, Joel M. Bernstein, Anthony M. Yurchak, Peter R. Coppola, Thomas B. Tomasi   +4 more
openalex   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Cellular Immunity in Chronic Theiler's Virus Central Nervous System Infection [PDF]

, 1976
Stanley G. Rabinowitz, Howard L. Lipton
openalex   +1 more source

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

Molecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez, Pablo Juanes‐Velasco, Marina L. García‐Vaquero, Conrad Droste, Alicia Landeira‐Viñuela, Miguel Alcoceba, Helena Fidalgo‐Gómez, Sara Misiego‐Herrero, Almudena Navarro‐Bailón, Mónica Baile, José M. Bastida, Jose Manuel Sanchez‐Santos, Rafael Góngora, Julia Almeida, Marcos Gonzalez‐Diaz, Alberto Orfao, Javier De Las Rivas, Manuel Fuentes   +17 more
wiley   +1 more source

Studies on the effector cell of anti-tumour immunity in a chemically induced mouse tumour system

, 1975
Richard B. Whitney, Julia G. Levy, Anajane G. Smith   +2 more
openalex   +1 more source

Effect of Chronic Viral Infection on the Immune System [PDF]

, 1973
Michael B. A. Oldstone, Antoinette Tishon, Jacques M. Chiller, William O. Weigle, Frank J. Dixon   +4 more
openalex   +1 more source

Bifidobacteria-mediated immune system imprinting early in life

Cell, 2020
B. Henrick, L. Rodriguez, T. Lakshmikanth, Christian Pou, E. Henckel, E. Henckel, E. Henckel, Axel Olin, Jun Wang, J. Mikeš, Ziyang Tan, Yang Chen, Amy M. Ehrlich, A. Bernhardsson, C. Mugabo, Ylva Ambrosiani, Anna Gustafsson, Anna Gustafsson, Stephanie Chew, H. Brown, Johann Prambs, Kajsa Bohlin, Kajsa Bohlin, Ryan D. Mitchell, M. Underwood, J. Smilowitz, J. German, S. Frese, P. Brodin, P. Brodin   +29 more
semanticscholar   +1 more source

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Rejuvenating the immune system. [PDF]

Mol Oncol
Evangelou K, Gorgoulis VG.
europepmc   +1 more source